NEW YORK, May 15, 2019 /PRNewswire/ -- Oppenheimer &
Co. Inc. ("Oppenheimer") – a leading investment bank, wealth
manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) –
will host its New York Oncology Insight Summit at The Barclay
Intercontinental Hotel in New York
City on May 16, 2019. This
event will feature 1-on-1 on meetings with companies focused in the
oncology space as well as hosting Key Opinion Leaders (KOLs) and
panelists discussing the latest advances and challenges in the
industry.
The gathering will showcase a diverse mix of companies
representing insight and focus across a range of research areas.
Companies participating include: Allogene, Aptose, BioXcel,
Constellation, Gamida Cell, Iovance Biotherapeutics, Molecular
Templates, Tyme, and Vaccinex.
The event will feature three panel discussions, moderated by
Oppenheimer Life Science research analysts, addressing key current
issues in oncology and healthcare as follows:
- The Changing Paradigms in Oncology
Treatment with Dr. Daniel
Cho and Dr. Francisco Esteva
of NYU Langone Medical Center
- The Mechanics of Drug Pricing within the Cancer Treatment
Landscape with Dr. Peter
Bach, Director of Memorial Sloan
Kettering's Center for Health Policy and Outcomes
- Emerging Therapies in Oncology with Dr.
Robert Fine, of Columbia University Comprehensive Cancer Center,
and Dr. Joshua Sabari, of NYU School
of Medicine
Oppenheimer Senior Research Analysts will also be in attendance
to offer additional insights:
- Jay Olson, Managing Director and
Senior Analyst covering Biopharmaceuticals
- Mark Breidenbach, Ph.D.,
Executive Director and Senior Analyst covering Biotechnology
- Kevin DeGeeter, Managing
Director and Senior Analyst covering Biotechnology
- Leland Gershell, Managing
Director and Senior Analyst covering Biotechnology
- Hartaj Singh, Managing Director and Senior
Analyst covering Biotechnology
"As a leader in life science and biotechnology equity research,
we are pleased to offer our clients access to prominent scientists
and companies, enabling them to more closely examine emerging areas
of cancer treatment and therapy and to showcase the significant
investment opportunities presented by these companies," said
Erica L. Moffett, Managing Director
and Associate Director of Research at Oppenheimer.
Oppenheimer's next conference is MedTech Day, which will be held
on May 29, 2019 in San Francisco, CA. Additionally, Oppenheimer's
Summit for Emerging Biotechnology will take place on June 26-28, 2019 in Montauk, NY.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc.
(Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc.
(OPY on the New York Stock Exchange), and its affiliates provide a
full range of wealth management, securities brokerage and
investment banking services to high-net-worth individuals,
families, corporate executives, local governments, businesses and
institutions.
View original
content:http://www.prnewswire.com/news-releases/investors-and-biotech-leaders-gather-in-new-york-for-oppenheimers-oncology-insight-summit-300851030.html
SOURCE Oppenheimer & Co. Inc.